Skip to content

Drug interactions

Tafamidis + Topotecan

Severity: Minor

Tafamidis and Topotecan: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tafamidis inhibits BCRP in vitro and may increase exposure to BCRP substrates such as topotecan. The effect on topotecan has not been well characterized, but higher levels could increase myelosuppression.

What this interaction means in plain words

Tafamidis and Topotecan have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Tafamidis belongs to Cardiovascular; Topotecan belongs to Oncology.

Evidence level: Low

Why it happens

Tafamidis inhibits BCRP, which can reduce topotecan efflux.

What to do

Monitor blood counts during topotecan therapy and lower the topotecan dose if toxicity occurs.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Tafamidis and Topotecan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Tafamidis with Topotecan?

MediHelp rates the interaction as minor. Tafamidis and Topotecan have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Tafamidis inhibits BCRP in vitro and may increase exposure to BCRP substrates such as topotecan. The effect on topotecan has not been well characterized, but higher levels could increase myelosuppression.

How serious is the interaction between Tafamidis and Topotecan?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts during topotecan therapy and lower the topotecan dose if toxicity occurs.

What other medicines interact with Topotecan?

MediHelp also lists interactions of Topotecan with, for example, Adenovirus types 4 and 7 live, Amiodarone, Cisplatin. The full list is on the Topotecan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in